1 / 31

SelSA Compounds as HDAC Inhibitors

Katherine Tai Mentor: Mohaiza Dashwood Advisor: Rod Dashwood Department of Environmental & Molecular Toxicology Linus Pauling Institute. SelSA Compounds as HDAC Inhibitors. Purpose:.

elinor
Télécharger la présentation

SelSA Compounds as HDAC Inhibitors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Katherine Tai Mentor: MohaizaDashwood Advisor: Rod Dashwood Department of Environmental & Molecular Toxicology Linus Pauling Institute SelSA Compounds as HDAC Inhibitors

  2. Purpose: • To determine the anticancer effects of compounds SelSA-1 and SelSA-2 in cancer cells HCT 116 (colon cancer) and A431 (skin cancer) in vitro.

  3. Histone post translational modifications

  4. Histone Acetylation and Deacetylation http://missinglink.ucsf.edu/lm/genes_and_genomes/acetylation.html

  5. Histone Acetylation • Acetylated histones are usually associated with transcriptionally active chromatin • Histones are acetylated by Histone Acetyltransferases (HATs) • Deacetylatedhistones are usually associated with inactive chromatin • Histones are deacetylated by Histone Deacetylases (HDACs)

  6. Classes of HDACs • 4 classes of HDACs: • Class I: HDAC1, 2, 3, 8 • Class II: HDAC4, 5, 6, 7, 9, 10 • Class III: Sir2(yeast), SirT1, 2, 3, 4, 5, 6, 7 • Class IV: HDAC11

  7. Cancer Therapy with HDAC Inhibitors • Histone Deacetylase (HDAC) inhibition has been shown to elicit anticancer effects in several tumor cells by inhibition of cell growth (Desai et al, 2009) • HDAC inhibitors can induce p21 (WAF1) expression, a regulator of p53's tumor suppressor activity. (Richonetal, 2000) • HDAC inhibitors are currently used for anti-cancer chemotherapy (Desai et al, 2009)

  8. Classes of HDAC Inhibitors • Hydroxamic Acids • Short-Chain Fatty Acids • Cyclic Tetrapeptides/epoxides • Aminobenzamides • Electrophilicketones

  9. O H NH N OH O Vorinostat (SAHA)(FDA Approved HDAC Inhibitor) • Vorinostat or suberoylanilide hydroxamic acid (SAHA) is a member of a larger class of compounds that inhibit histone deacetylases (HDAC). • Histone deacetylase inhibitors (HDI) have a broad spectrum of epigenetic activities. • Vorinostat is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL) when the disease persists, gets worse, or comes back during or after treatment with other medicines. (Merck & Co., 2006)

  10. O H H H NH N N N OH O O O H N Se Se O SeCN SelSA Compounds • Organoselenium compounds have been shown to be HDAC inhibitors and reduce growth of colon and prostate cancer cells (Nian et al, 2009) • Two selenium analogs of SAHA have been reported as potent HDAC inhibitors (Desai et al, 2009) SAHA Selenocyanide (SelSA-2) Selenium Dimer (SelSA-1)

  11. Hypothesis • Test SAHA derivatives SelSA-1 and SelSA-2 for their anti-cancer activity on cancer cell lines in vitro: • HCT116 (colon carcinoma) • A431 (skin carcinoma) • Test SelSA-1 and -2 for their effect on HDAC activity and histone acetylation. • Test for cellular effects i.e. morphology, growth, cell cycle and cell death on cancer cells.

  12. HDAC activity assay • The method requires two steps, both performed on the same microtiter plate. • First, the HDAC fluorogenic substrate, which comprises an acetylated lysine side chain, is incubated with a sample containing HDAC activity (e.g., HeLa nuclear extract). • Deacetylation of the substrate sensitizes the substrate, so that, in the second step, treatment with the Lysine Developer produces a fluorophore. • The fluorophore can be analyzed using a fluorescence plate reader (Ex 360 nm/Em 460 nm). • A standard curve of deactylated substrate is run in parallel.

  13. Effect on HDAC Activity

  14. Western Blotting for HDAcs and Histone Modifications • IC50 concentrations were used. • Cancer cells were treated with SelSA-1, SelSA-2, and SAHA at 3, 6 and 24 hrs. • Cells were lysed and lysates collected. • Protein concentration in lysates was determined by BCA • Western blotting of equal amounts of protein was done on 4-12% Tris-Glycine pre-cast gels.

  15. Western Blots of Colon Cancer:HisH3 Acetylation SelSA-1 10μM SelSA-2 10μM SAHA-1 0.1μM SelSA-1 0.1μM SelSA-2 0.1μM SAHA-1 5μM SelSA-1 5μM SAHA 10μM DMSO SAHA-1 1μM SelSA-1 1μM No Treatment SelSA-2 5μM SelSA-2 1μM HisH3 (9-10-10) HisH3 Acetylated (9-10-10) HisH3 Acetylated K9 (9-10-10

  16. Western Blots of Colon Cancer:HisH4 Acetylation SAHA-1 0.1μM SelSA-1 0.1μM SelSA-2 10μM SelSA-2 0.1μM SelSA-1 10μM SAHA-1 5μM SelSA-1 5μM SAHA 10μM DMSO SAHA-1 1μM SelSA-1 1μM No Treatment SelSA-2 5μM SelSA-2 1μM HisH4 (9-10-10) HisH4 Acetylated (9-10-10) Relative Densitometry HisH4 Acetylated K12 (9-10-10 Relative Densitometry

  17. Western Blots of Colon Cancer:α-Tubulin acetylation SelSA-1 10μM SelSA-2 10μM SAHA-1 0.1μM SelSA-1 0.1μM SelSA-2 0.1μM SAHA-1 5μM SelSA-1 5μM SAHA 10μM DMSO SAHA-1 1μM SelSA-1 1μM No Treatment SelSA-2 5μM SelSA-2 1μM α-Tubulin Acetylated α-Tubulin

  18. Western Blots of Colon Cancer:Class I HDACs 3H 6H 24H β-Actin (8-9-10) HDAC1 (8-9-10) β-Actin (8-3-10) HDAC2 (8-3-10) HDAC8 (8-3-10) Treatments: None SelsA-1 SelsA-1 SelsA-2 SelsA-2 SAHA 2.5μM 5μM 2.5μM 5μM 5μM

  19. Western Blots of Colon Cancer:Class I HDACs SelSA-1 10μM SelSA-2 10μM SAHA-1 0.1μM SelSA-1 0.1μM SelSA-2 0.1μM SAHA-1 5μM SelSA-1 5μM SAHA 10μM DMSO SAHA-1 1μM SelSA-1 1μM No Treatment SelSA-2 5μM SelSA-2 1μM β-Actin (9-16-10) HDAC3 (9-16-10)

  20. Western Blots of Colon Cancer:Class II HDACs 3H 6H 24H β-Actin (8-3-10) HDAC10 (8-3-10) Treatments: None SelsA-1 SelsA-1 SelsA-2 SelsA-2 SAHA 2.5μM 5μM 2.5μM 5μM 5μM

  21. Western Blots of Colon Cancer:Class IV HDACs 3H 6H 24H β-Actin (8-3-10) HDAC11 (8-3-10) Treatments: None SelsA-1 SelsA-1 SelsA-2 SelsA-2 SAHA 2.5μM 5μM 2.5μM 5μM 5μM

  22. Western Blots of Skin Cancer:Class I HDACs 3H 6H 24H β-Actin (4-21-10) HDAC1 (4-21-10) HDAC2 (4-21-10) HDAC3 (6-21-10) HDAC8 (5-25-10) Treatments: None SelsA-1 SelsA-1 SelsA-2 SelsA-2 SAHA 1μM 5μM 1μM 5μM 5μM

  23. Western Blots of Skin Cancer:Class II HDACs 3H 6H 24H β-Actin (5-25-10) HDAC7 (5-25-10) β-Actin (6-21-10) HDAC10 (6-21-10) Treatments: None SelsA-1 SelsA-1 SelsA-2 SelsA-2 SAHA 1μM 5μM 1μM 5μM 5μM

  24. Effect on Colon Cancer Cell Morphology: DMSO SAHA All Compounds tested at 1μM for 72 hours

  25. Effect on Colon Cancer Cell Morphology: SELSA-1 SELSA-2 All Compounds tested at 1μM for 72 hours

  26. Cell Counting Kit-8 (CCK8) • Cell Counting Kit-8 is a nonradioactive, sensitive colorimetric assay for the determination of the number of viable cells in cell proliferation and cytotoxicity assays. • Half maximal inhibitory concentration (IC50): the half maximal (50%) inhibitory concentration (IC) of a substance measuring the effectiveness of a compound in inhibiting biological or biochemical function. • CCK8: WST-8 is reduced by dehydrogenases to give a formazan product. The amount of formazan dye generated, which is soluble in the cell culture medium, is proportional to number of living cells.

  27. CCK8 Assay-Dose Response 0fHCT116 Colon Cancer Cells (72 hrs) • CompoundIC50 (uM) • SAHA 0.8 • SELSA-1 0.6 • SELSA-2 0.9

  28. Ic50 of Organoselenium Compounds for 10,000 Skin (A431) Cancer Cells • IC50 • SelSA-1: 1.5 μM • SelSA-2: 1.75 μM • SAHA: 5 μM

  29. Cell Cycle Analysis Treatment increases apoptotic sub-G1 phase

  30. Conclusions • SelSA-1 and SelSA-2 inhibit HDAC activity and induce histone acetylation • These compounds were found to be moderately more potent than SAHA in the activity assay • These compounds inhibit cell growth and cause cell death in colon and skin cancer cells • SelSA-1 and SelSA-2 are important SAHA derivatives which need to be further tested in animal models

  31. Acknowledgements • HHMI Program • Kevin Ahern • Dashwood Lab • Dr. Roderick Dashwood • MohaizaDashwood • Praveen Rajendran • Rong Wang • HuiNian • Pennsylvania State Hershey College of Medicine

More Related